---
title: "Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293252727.md"
description: "Vertex Pharmaceuticals (VRTX) shares fell 1.06% to $480.50 on Monday, underperforming the broader market as the S&P 500 and Dow Jones also declined. This marks the second consecutive day of losses for VRTX, which remains near its 52-week high. Trading volume was below the 50-day average. While competitors like AbbVie and Krystal Biotech also saw declines, Vertex's drop was more pronounced relative to some peers."
datetime: "2026-07-20T20:37:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293252727.md)
  - [en](https://longbridge.com/en/news/293252727.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293252727.md)
---

# Vertex Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Vertex Pharmaceuticals Inc. (VRTX) slid 1.06% to $480.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.19% to 7,443.28 and Dow Jones Industrial Average falling 0.59% to 51,839.26.

This was the stock's second consecutive day of losses.

Vertex Pharmaceuticals Inc. closed 9.96% short of its 52-week high of $533.67, which the company achieved on July 7th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.44% to $253.38, Krystal Biotech Inc. (KRYS) fell 4.41% to $339.22, and Arcturus Therapeutics Holdings Inc. (ARCT) fell 1.32% to $5.97.

Trading volume (1.1 M) remained 499,021 below its 50-day average volume of 1.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 20, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-20-26 1637ET

### Related Stocks

- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [KRYS.US](https://longbridge.com/en/quote/KRYS.US.md)
- [ARCT.US](https://longbridge.com/en/quote/ARCT.US.md)

## Related News & Research

- [$100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/295956299.md)
- [TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296021261.md)
- [Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/296018925.md)
- [Vertex Pharmaceuticals (VRTX) Receives a Buy from BMO Capital](https://longbridge.com/en/news/296223201.md)
- [Crinetics-Vertex deal clears US antitrust waiting period, other approvals in hand](https://longbridge.com/en/news/295935333.md)